🇺🇸 FDA
Pipeline program

-, PARACETAMOL , CILAZAPRIL , Dapirolizumab pegol, EPINEPHRINE , DIPHENHYDRAMINE , -, -, -, -, -, -, -

SL0046

Phase 3 small_molecule active

Quick answer

-, PARACETAMOL , CILAZAPRIL , Dapirolizumab pegol, EPINEPHRINE , DIPHENHYDRAMINE , -, -, -, -, -, -, - for Systemic lupus erythematosus (SLE) is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Systemic lupus erythematosus (SLE)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials